110 related articles for article (PubMed ID: 7139649)
1. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Boesen E; Mouridsen HT
Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
[TBL] [Abstract][Full Text] [Related]
2. Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.
Mouridsen HT; Boesen E
Breast Cancer Res Treat; 1983; 3(1):85-9. PubMed ID: 6871484
[TBL] [Abstract][Full Text] [Related]
3. Combined cytotoxic and endocrine treatment of postmenopausal patients with advanced breast cancer: preliminary results of a phase II study of the combination of prednimustine, novantrone, methotrexate, 5-fluorouracil, and tamoxifen.
Mouridsen HT; Andersson M; Pedersen L
Semin Oncol; 1986 Mar; 13(1 Suppl 1):39-41. PubMed ID: 3952520
[TBL] [Abstract][Full Text] [Related]
4. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
5. Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
Marini G; Simoncini E; Marpicati P; Montini E; Ferrari V; Arcangeli G; Zaniboni A
Chemioterapia; 1988 Apr; 7(2):130-2. PubMed ID: 2840216
[TBL] [Abstract][Full Text] [Related]
6. Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial.
Andersson M; Mouridsen HT
Acta Oncol; 1988; 27(3):235-9. PubMed ID: 3415852
[TBL] [Abstract][Full Text] [Related]
7. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone, methotrexate and chlorambucil in metastatic breast cancer, a combination with relatively low subjective toxicity.
Burghouts JT
Neth J Med; 1990 Feb; 36(1-2):43-5. PubMed ID: 2314519
[TBL] [Abstract][Full Text] [Related]
9. Prednimustine (Sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer.
Yosef H; Slater A; Keen CW; Bunting JS; Hope-Stone H; Parmar H; Roberts JT; Termander B; Nilsson B
Eur J Cancer; 1993; 29A(8):1100-5. PubMed ID: 8518020
[TBL] [Abstract][Full Text] [Related]
10. Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Samonigg H; Stöger H; Kasparek AK; Schmid M; Dusleag J; Pfeiffer K; Smola M; Steindorfer P; Lechner P
Cancer Chemother Pharmacol; 1991; 27(6):477-80. PubMed ID: 2013118
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
13. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
Paul DM; Garrett AM; Meshad M; DeVore RD; Porter LL; Johnson DH
Semin Oncol; 1996 Feb; 23(1 Suppl 1):48-52. PubMed ID: 8629038
[TBL] [Abstract][Full Text] [Related]
15. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
[TBL] [Abstract][Full Text] [Related]
16. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of prednimustine in glioblastoma multiforme.
Andersen J; Christensen L; Kongsholm H
Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
[TBL] [Abstract][Full Text] [Related]
18. [Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers].
Conroy T; Wils J; Paillot B; Wagener DJ; Burghouts JT; Fickers MM; de Graeff A; Lalisang FM
Bull Cancer; 1993 Mar; 80(3):255-60. PubMed ID: 8173178
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
